Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00478322 · ClinicalTrials.gov registry record · Phase 2

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

A Phase 2 study of Obesity and Diabetes Mellitus, Type 2, sponsored by Incyte Corporation.

Completed
Registry status
Phase 2
Development phase
24
Enrollment target
3
Study locations

NCT00478322 is a Phase 2 study of Obesity and Diabetes Mellitus, Type 2 that has completed, run by Incyte Corporation. The registered enrollment target is 24 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00478322, a Phase 2 study of Obesity and Diabetes Mellitus, Type 2, has completed, sponsored by Incyte Corporation.

COMPLETED
Registry status
Phase 2
Development phase
24 participants
Enrollment target
3
Study locations

Study Summary

Purpose: A 28-day US study in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug.

Conditions Studied

Obesity Diabetes Mellitus, Type 2

Interventions

  • DRUG Placebo
  • DRUG INCB013739

Study Locations (3)

California

  • - Chula Vista

New York

  • - The Bronx

Texas

  • - San Antonio

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2007-04
Est. Completion 2008-02
Phase Phase 2

Sponsor

Incyte Corporation

239 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00478322

The ClinicalTrials.gov registry entry for NCT00478322 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00478322 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT00478322 about?

NCT00478322 is a clinical study titled "Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects". Purpose: A 28-day US study in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug.

What is the current status of trial NCT00478322?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2007-04. Estimated completion is 2008-02.

What conditions does trial NCT00478322 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00478322?

The interventions under investigation include: Placebo (DRUG), INCB013739 (DRUG).

Who is sponsoring clinical trial NCT00478322?

This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00478322 being conducted?

This trial has 3 study locations across California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Diabetes Mellitus, Type 2

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.